rs387906356
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4_SupportingPP5
The NM_006412.4(AGPAT2):c.418_420del(p.Phe140del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,612,458 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
AGPAT2
NM_006412.4 inframe_deletion
NM_006412.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.20
Genes affected
AGPAT2 (HGNC:325): (1-acylglycerol-3-phosphate O-acyltransferase 2) This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_006412.4. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 9-136677032-TGAA-T is Pathogenic according to our data. Variant chr9-136677032-TGAA-T is described in ClinVar as [Pathogenic]. Clinvar id is 6628.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGPAT2 | NM_006412.4 | c.418_420del | p.Phe140del | inframe_deletion | 3/6 | ENST00000371696.7 | NP_006403.2 | |
AGPAT2 | NM_001012727.2 | c.418_420del | p.Phe140del | inframe_deletion | 3/5 | NP_001012745.1 | ||
AGPAT2 | XM_047422636.1 | c.109_111del | p.Phe37del | inframe_deletion | 3/6 | XP_047278592.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGPAT2 | ENST00000371696.7 | c.418_420del | p.Phe140del | inframe_deletion | 3/6 | 1 | NM_006412.4 | ENSP00000360761 | P1 | |
AGPAT2 | ENST00000371694.7 | c.418_420del | p.Phe140del | inframe_deletion | 3/5 | 1 | ENSP00000360759 | |||
AGPAT2 | ENST00000472820.1 | n.346_348del | non_coding_transcript_exon_variant | 1/4 | 1 | |||||
AGPAT2 | ENST00000470861.1 | n.712_714del | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151542Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151542
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460916Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 726762
GnomAD4 exome
AF:
AC:
5
AN:
1460916
Hom.:
AF XY:
AC XY:
3
AN XY:
726762
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151542Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73984
GnomAD4 genome
AF:
AC:
1
AN:
151542
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73984
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Congenital generalized lipodystrophy type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2002 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at